首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1402418

誘導性多功能幹細胞(iPSC)：全球市場

Induced Pluripotent Stem Cells: Global Markets

出版日期: 2024年01月04日 | 出版商:

BCC Research | 英文 121 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球誘導性多功能幹細胞（iPSC）市場規模預計將從2023年的34億美元成長到2028年終的52億美元，預測期內複合年成長率為9.1%。

預計到 2028年終，非綜合法律部門將從 2023 年的 21 億美元增加到 34 億美元，複合年成長率為 10.1%。此外，綜合法律部門預計到 2028年終將從 2023 年的 13 億美元增加到 18 億美元，複合年成長率為 7.5%。

本報告調查了全球誘導性多功能幹細胞（iPSC）市場，提供了市場的定義和概述、市場影響因素分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析以及競爭形勢。，其中彙編了主要企業的概況。

市場概況
美國
歐洲
亞太地區
iPSC 的生成
市場概況：依應用分類
iPSC產品市場
iPSC 衍生的組織細胞市場
任務
iPSC 及其衍生細胞市場：類型
世界市場
iPSC 產品的領先供應商和製造商
iPSC 市場：依應用分類
iPSC 市場：依產品特性
世界市場
區域市場
iPSC 市場：以最終用戶分類

第 7 章：誘導性多功能幹細胞(iPSC) 研究使用市場

iPSC 研究產品類型
主要企業
主要商業組織
主要非營利組織
市場佔有率/預測

第8章誘導性多功能幹細胞（iPSC）合約服務市場

iPSC合約服務類型
主要企業
市場佔有率/預測

第9章臨床使用市場趨勢分析

臨床試驗
老齡化黃斑部病變
缺血性心臟疾病
帕金森氏症
移植物抗宿主疾病（GvHD）
脊髓損傷
角膜修復
癌症
推進因素
抑制因素
科技
規則
市場接受度
臨床效率

第10章競爭形勢

M&A
策略聯盟

第11章公司簡介

ADDGENE
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
ALSTEM
APPLIED BIOLOGICAL MATERIALS INC.（ABM）
APPLIED STEMCELL INC.
ATCC
AXOL BIOSCIENCE LTD.
BIO-TECHNE CORP.
BLUEROCK THERAPEUTICS
BRISTOL MYERS SQUIBB（IPIERIAN）
CELL SIGNALING TECHNOLOGY（CST）
CORNING INC.
CREATIVE BIOARRAY
FATE THERAPEUTICS
FUJIFILM CELLULAR DYNAMICS INC.（FCDI）
GENECOPOEIA INC.
GENTARGET INC.
ID PHARMA CO. LTD.
INVIVOGEN
LONZA GROUP LTD.
MEGAKARYON CORP.
MERCK KGAA
NCARDIA
NEWCELLS BIOTECH
PEPROTECH INC.
PLASTICELL LTD.
PROMEGA CORP.
PROMOCELL GMBH
QIAGEN NV
REPROCELL INC.
SCIENCELL RESEARCH LABORATORIES
STEMCELL TECHNOLOGIES
SYSTEM BIOSCIENCES INC.
TAKARA BIO USA INC.（CLONTECH LABORATORIES）
THERMO FISHER SCIENTIFIC
VERTEX PHARMACEUTICALS INC.
WAISMAN BIOMANUFACTURING

第 12 章附錄：縮寫

簡介目錄圖表

Product Code: BIO135E

Highlights:

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 and forecast to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 through 2028.

The global market for iPSCs generated by non-integrated method is expected to grow from $2.1 billion in 2023 and forecast to reach $3.4 billion by the end of 2028, at a CAGR of 10.1% from 2023 through 2028.

The global market for iPSCs generated by integrated method is expected to grow from $1.3 billion in 2023 and forecast to reach $1.8 billion by the end of 2028, at a CAGR of 7.5% from 2023 through 2028.

Report Scope:

This study focuses on the market side of iPSCs rather than the technical side. Different market segments for this emerging market are covered. For instance, product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation, and cell analysis. Application-based market segments include drug development and toxicity testing, academic research, and regenerative medicine. iPSC-derived cell type-based market segments include hepatocytes, neurons, cardiomyocytes, endothelial cells, and other cell types. Other cell types are comprised of astrocytes, fibroblasts, and hematopoietic and progenitor cells, among other substances. Geographical-based market segments include the U.S., Asia-Pacific, Europe, and the Rest of the World. The research and market trends are also analyzed by studying the funding, patent publications, and research publications in the field.

This report focuses on the market size and segmentation of iPSC products, including iPSC research and clinical products. The market for iPSC-related contract services is also discussed. iPSC research products are defined as all research tools, including iPSCs and various differentiated cells derived from iPSCs, various related assays and kits, culture media and medium components (e.g., serum, growth factors, inhibitors), antibodies, enzymes, and products that can be applied for the specific purpose of executing iPSC research. For this report, iPSC products do not cover stem cell research and clinical products that are broadly applicable to any stem cell type.

This report discusses key manufacturers, technologies, and factors influencing market demand, including the driving forces and limiting factors of the iPSC market's growth. Based on these facts and analysis, the market trends and sales for research and clinical applications are forecast through 2028. One particular focus on the application of iPSCs was given to drug discovery and development, which includes pharmaco-toxicity screening, lead generation, target identification, and other preclinical studies; body-on-a-chip; and 3D disease modeling. Suppliers and manufacturers of iPSC-related products are discussed and analyzed based on their market shares, product types, and geography. An in-depth patent analysis and research funding analysis are also included to assess the overall direction of the iPSC market.

Detailed technologies such as those for generating iPSCs, differentiating iPSCs and controlling the differentiation, and large-scale manufacturing of iPSCs and their derivative cells under Good Manufacturing Practice (GMP) compliance or xeno-free conditions are excluded from the study. They are beyond the scope of this report.

The induced pluripotent stem cell market has been analyzed for four main geographic regions: The U.S., Europe, Asia-Pacific, and the Rest of the World (RoW). The report will provide details with respect to induced pluripotent stem cells.

Report Includes:

34 data tables
An overview of the global market for induced pluripotent stem cells (iPSCs)
Analysis of global market trends, featuring historical revenue data for 2021 and 2022, estimated figures for 2023, as well as forecasts for 2028, including projections of compound annual growth rates (CAGRs) through 2028
Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by reprogramming method, method, application, derived tissue cell type, species, product function, end use, and geographic region
Analysis of the market's dynamics, including drivers, restraints and opportunities, and the regulatory environments impacting the market
Assessment of R&D activity in the iPSC segment, as well as new developments and pipeline products
Information on the latest research activities, emerging technologies, and clinical trials
Market share analysis of the key companies and coverage of mergers & acquisitions, joint ventures, collaborations, and partnerships
Profiles of the major players in the industry

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Market Summary

Chapter 3 Market Overview

Introduction
Pluripotency Factors
Research and Therapeutic Significance

Chapter 4 Market Dynamics

Market Drivers
Growing Research and Development in iPSCs
Increased Investment in Biotechnology Industry
Rising Prevalence of Chronic Diseases
Use of iPSCs in Precision Medicine

Chapter 5 Induced Pluripotent Stem Cell Applications

Academic Research
Pharmaco-toxicological Screening
Drug Discovery and Development
Disease Modeling
Tissue Engineering
Cell Therapy
Emerging Technologies

Chapter 6 Induced Pluripotent Stem Cell Market Segmentation and Forecast

Market Overview
U.S.
Europe
Asia-Pacific
Generation of Induced Pluripotent Stem Cells
Application-based Market Overview
Induced Pluripotent Stem Cells Product Market
Induced Pluripotent Stem Cell-derived Tissue Cell Market
Challenges
Induced Pluripotent Stem Cells and Their Derivative Cell Market, by Species
Global Market
Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
Market for Induced Pluripotent Stem Cell-derived Cells, by Application
Market for Induced Pluripotent Stem Cells, by Product Function
Global Market
Regional Markets
Market for Induced Pluripotent Stem Cells, by End Use

Chapter 7 Induced Pluripotent Stem Cells Research Application Market

Induced Pluripotent Stem Cells Research Product Types
Major Players
Major Commercial Entities
Major Noncommercial Organizations
Market Shares and Projections

Chapter 8 Induced Pluripotent Stem Cell Contract Service Market

Induced Pluripotent Stem Cell Contract Service Types
Major Players
Market Shares and Projections

Chapter 9 Clinical Application Market Trend Analysis

Clinical Trials
Age-related Macular Degeneration
Ischemic Heart Disease
Parkinson's Disease
Graft-versus-host Disease (GvHD)
Spinal Cord Injuries
Corneal Repair
Cancer
Driving Forces
Limiting Factors
Technologies
Regulations
Market Acceptance
Clinical Efficiency

Chapter 10 Competitive Landscape

Mergers and Acquisitions
Strategic Alliances

Chapter 11 Company Profiles

ADDGENE
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
ALSTEM
APPLIED BIOLOGICAL MATERIALS INC. (ABM)
APPLIED STEMCELL INC.
ATCC
AXOL BIOSCIENCE LTD.
BIO-TECHNE CORP.
BLUEROCK THERAPEUTICS
BRISTOL MYERS SQUIBB (IPIERIAN)
CELL SIGNALING TECHNOLOGY (CST)
CORNING INC.
CREATIVE BIOARRAY‎
FATE THERAPEUTICS
FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
GENECOPOEIA INC.
GENTARGET INC.
ID PHARMA CO. LTD.
INVIVOGEN
LONZA GROUP LTD.
MEGAKARYON CORP.
MERCK KGAA
NCARDIA
NEWCELLS BIOTECH
PEPROTECH INC.
PLASTICELL LTD.
PROMEGA CORP.
PROMOCELL GMBH
QIAGEN NV
REPROCELL INC.
SCIENCELL RESEARCH LABORATORIES
STEMCELL TECHNOLOGIES‎
SYSTEM BIOSCIENCES INC.
TAKARA BIO USA INC. (CLONTECH LABORATORIES)
THERMO FISHER SCIENTIFIC
VERTEX PHARMACEUTICALS INC.
WAISMAN BIOMANUFACTURING

Chapter 12 Appendix: Acronyms

簡介目錄圖表

List of Tables

Summary Table : Global Market for Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028
Table 1 : Global Market for Induced Pluripotent Stem Cells, by Region, Through 2028
Table 2 : U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2028
Table 3 : European Market for Induced Pluripotent Stem Cells, by Country, Through 2028
Table 4 : Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2028
Table 5 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028
Table 6 : Global Market for Induced Pluripotent Stem Cells, by Method, Through 2028
Table 7 : Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 8 : U.S. Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 9 : European Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 10 : Asia-Pacific Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 11 : Rest of the World Market for Induced Pluripotent Stem Cell Products, by Application, Through 2028
Table 12 : Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, Through 2028
Table 13 : Global Market for Induced Pluripotent Stem Cell-derived Cells, by Species, Through 2028
Table 14 : Major Commercial Suppliers of Induced Pluripotent Stem Cell Products, by Country
Table 15 : Major Commercial Manufacturers of Induced Pluripotent Stem Cells, by Country
Table 16 : Global Market for Induced Pluripotent Stem Cell-derived Cells, by Application, Through 2028
Table 17 : Global Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 18 : U.S. Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 19 : European Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 20 : Asia-Pacific Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 21 : RoW Market for Induced Pluripotent Stem Cell-related Products, by Product Function, Through 2028
Table 22 : Global Market for Induced Pluripotent Stem Cells, by End Use, Through 2028
Table 23 : Global Market for Induced Pluripotent Stem Cell-related Products, by Function, Through 2028
Table 24 : Major University and Institute Facilities for Induced Pluripotent Stem Cell Research, by Location/Country
Table 25 : Major Companies Providing iPSC Contract Services, by State/Country
Table 26 : Global Market for Induced Pluripotent Stem Cell Contract Services, by Region, Through 2028
Table 27 : Induced Pluripotent Stem Cells Pipeline (Interventional Trials)*
Table 28 : Bio-Techne: Annual Financials/Revenue, 2022
Table 29 : Bristol Myers Squibb: Financials/Revenue, 2022
Table 30 : Corning Inc.: Financials/Revenue, 2022
Table 31 : Qiagen NV: Annual Financials/Revenue, 2022
Table 32 : Thermo Fisher Scientific: Annual Financials/Revenue, 2022
Table 33 : Acronyms Used in the iPSCs Industry

List of Figures

Summary Figure : Global Market for Induced Pluripotent Stem Cells, by Reprogramming Method, 2021-2028
Figure 1 : Global Market Share of Induced Pluripotent Stem Cells, by Region, 2022
Figure 2 : U.S. Market Share of Induced Pluripotent Stem Cells, by State, 2022
Figure 3 : European Market Share of Induced Pluripotent Stem Cells, by Country, 2028
Figure 4 : Asia-Pacific Market Share of Induced Pluripotent Stem Cells, by Country, 2022
Figure 5 : Global Market Share of Induced Pluripotent Stem Cells, by Reprogramming Method, 2022
Figure 6 : Global Market Share of Induced Pluripotent Stem Cells, by Method, 2022
Figure 7 : Global Market Share of Induced Pluripotent Stem Cell Products, by Application, 2022
Figure 8 : U.S. Market Share of Induced Pluripotent Stem Cell Products, by Application, 2022
Figure 9 : European Market Share of Induced Pluripotent Stem Cell Products, by Application, 2022
Figure 10 : Asia-Pacific Market Share of Induced Pluripotent Stem Cell Products, by Application, 2022
Figure 11 : Rest of the World Market Share of Induced Pluripotent Stem Cell Products, by Application, 2022
Figure 12 : Global Market Share of Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, 2022
Figure 13 : Global Market Share of Induced Pluripotent Stem Cell-derived Cells, by Application, 2022
Figure 14 : Global Market Share of Induced Pluripotent Stem Cell-related Products, by Product Function, 2022
Figure 15 : U.S. Market Share of Induced Pluripotent Stem Cell-related Products, by Product Function, 2022
Figure 16 : European Market Share of Induced Pluripotent Stem Cell-related Products, by Product Function, 2022
Figure 17 : Asia-Pacific Market Share of Induced Pluripotent Stem Cell-related Products, by Product Function, 2022
Figure 18 : RoW Market Share of Induced Pluripotent Stem Cell-related Products, by Product Function, 2022
Figure 19 : Global Market Share of Induced Pluripotent Stem Cells, by End Use, 2022
Figure 20 : Global Market Share of Induced Pluripotent Stem Cell-related Products, by Function, 2022
Figure 21 : Global Market Share of Induced Pluripotent Stem Cell Contract Services, by Region, 2022
Figure 22 : Clinical-trial Analysis: Induced Pluripotent Stem Cells
Figure 23 : Bio-Techne: Annual Financials/Revenue, 2021 and 2022
Figure 24 : Bio-Techne: Revenue Share, by Country/Region, 2022
Figure 25 : Bio-Techne: Revenue Share, by Business Segment, 2022
Figure 26 : Bristol Myers Squibb: Financials/Revenue, 2021 and 2022
Figure 27 : Bristol Myers Squibb: Revenue Share, by Business Unit, 2022
Figure 28 : Bristol Myers Squibb: Revenue Share, by Country/Region, 2022
Figure 29 : Corning Inc.: Financials/Revenue, 2021 and 2022
Figure 30 : Corning Inc.: Revenue Share, by Business Segment, 2022
Figure 31 : Qiagen NV: Annual Financials/Revenue, 2021 and 2022
Figure 32 : Qiagen NV: Revenue Share, by Business Unit, 2022
Figure 33 : Qiagen NV: Revenue Share, by Region, 2022
Figure 34 : Thermo Fisher Scientific: Annual Financials/Revenue, 2021 and 2022
Figure 35 : Thermo Fisher Scientific: Revenue Share, by Business Unit, 2022
Figure 36 : Thermo Fisher Scientific: Revenue Share, by Region, 2022